Entrada Therapeutics (TRDA) Earnings Date & Reports
A.I. Advisor
published Earnings
TRDA is expected to report earnings to fall 149.16% to -76 cents per share on November 05
Q3'24
Est.
$-0.76
Q2'24
Beat
by $1.19
Q1'24
Beat
by $1.27
Q4'23
Missed
by $0.12
Q3'23
Beat
by $1.76
The last earnings report on August 13 showed earnings per share of $1.55, beating the estimate of 36 cents. With 82.03K shares outstanding, the current market capitalization sits at 572.50M.